The impact of placental massive perivillous fibrin deposition on neonatal outcome in pregnancies complicated by fetal growth restriction

被引:17
|
作者
Spinillo, Arsenio [1 ]
Gardella, Barbara [1 ]
Muscettola, Giulia [1 ]
Cesari, Stefania [2 ]
Fiandrino, Giacomo [2 ]
Tzialla, Chryssoula [3 ]
机构
[1] Univ Pavia, Dept Obstet & Gynecol, Piazzale Golgi 19, Pavia, Italy
[2] Univ Pavia, Dept Pathol, Piazzale Golgi 19, Pavia, Italy
[3] Univ Pavia, IRCCS, Neonatal Intens Care Unit, Fdn Policlin San Matteo, Piazzale Golgi 19, Pavia, Italy
关键词
Fetal growth restriction; Perivillous fibrin deposition; Fetal vascular malperfusion; Maternal vascular malperfusion; Neonatal adverse outcome; CLINICAL-SIGNIFICANCE; POPULATION;
D O I
10.1016/j.placenta.2019.09.007
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Introduction: Massive perivillous fibrin deposition (MPDD) is an uncommon placental lesion which has been associated with an increased risk of adverse pregnancy outcome in retrospective series. The purpose of the study was to evaluate the frequency and consequences of MPFD in pregnancies complicated by fetal growth restriction (FGR). Materials and methods: A cohort study of 355 pregnancies complicated by FGR diagnosed according to standard ultrasonographic criteria, enrolled, followed and delivered at a single obstetric unit. Pathological placental lesions were classified according to the Amsterdam Placental Workshop Consensus. Penalized logistic regression models were used to evaluate the association of MPFD with maternal risk factors, other pathological lesions and neonatal outcome. Results: The rates of moderate (25-50% of villi) and severe (> 50% of villi) MPFD were 8.7% (31/355) and 3.1% (11/355), respectively. Compared to other FGR cases, MPFD pregnancies were characterized by higher placental volume (450 +/- 144.5 SD as compared to 412.2 +/- 151 cm(3),p < 0.001) and lower birthweight/placental weight ratio (5.32 +/- 1.53 compared to 6.1 +/- 1.52,p < 0.001). The rates of abnormal Doppler ultrasound studies of umbilical and middle cerebral artery were similar in MPFD subjects and controls. After correction for gestational age and birthweight, MPFD was associated with an increased risk of neonatal intraventricular hemorrhage (> grade II) (OR = 5.66,95% CI = 1.69-18.97), sepsis (OR = 5.9, 95% CI = 1.27-27.12), proven necrotizing enterocolitis (OR = 9.84,95% CI = 2.49-38.8) and overall severe adverse neonatal outcome (OR = 5.71,95% CI = 2.05-15.87). Conclusions: Moderate-to-severe MPFD was relatively common among FGR pregnancies and was associated with morphometric modifications of placenta and with an increased risk of severe adverse neonatal outcome.
引用
收藏
页码:46 / 52
页数:7
相关论文
共 50 条
  • [31] Predictive index for adverse perinatal outcome in pregnancies complicated by fetal growth restriction
    Powel, J. E.
    Zantow, E. W.
    Bialko, M. F.
    Farley, L. G.
    Lawlor, M. L.
    Mullan, S. J.
    Vricella, L. K.
    Tomlinson, T. M.
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2023, 61 (03) : 367 - 376
  • [32] Pravastatin to prevent recurrent fetal death in massive perivillous fibrin deposition of the placenta (MPFD)
    Chaiworapongsa, Tinnakorn
    Romero, Roberto
    Korzeniewski, Steven J.
    Chaemsaithong, Piya
    Hernandez-Andrade, Edgar
    Segars, James H.
    DeCherney, Alan H.
    McCoy, M. Cathleen
    Kim, Chong Jai
    Yeo, Lami
    Hassan, Sonia S.
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2016, 29 (06): : 855 - 862
  • [33] Massive Perivillous Fibrin Deposition-A Cause of Recurrent Fetal Demise: A Case Report
    Pandiri, M.
    Kashikar, R.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2021, 156 : S147 - S147
  • [34] Recurrent placental massive perivillous fibrin deposition associated with polymyositis: A case report and review of the literature
    Al-Adnani, Mudher
    Kiho, Dina
    Scheimberg, Irene
    PEDIATRIC AND DEVELOPMENTAL PATHOLOGY, 2008, 11 (03) : 226 - 229
  • [35] Placental dysfunction in uncomplicated and complicated intrauterine growth restriction by preeclampsia and neonatal outcome
    Tagliaferri, Salvatore
    Travaglino, Antonio
    Raffone, Antonio
    Saccone, Gabriele
    Campanino, Maria Raffaela
    Zara, Giuseppe
    Ammendola, Alessandra
    Pini, Nicolo
    Maruotti, Giuseppe Maria
    Magenes, Giovanni
    Signorini, Maria Gabriella
    Guida, Maurizio
    Zullo, Fulvio
    D'Armiento, Maria
    Campanile, Marta
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2022, 35 (25): : 8169 - 8175
  • [36] Placental pathology and neonatal outcome among growth-restricted fetuses in pregnancies complicated by preeclampsia, idiopathic growth restriction, and intrauterine inflammation
    Mcelrath, TF
    Allred, EN
    Leviton, A
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2003, 189 (06) : S220 - S220
  • [37] Placental Pathology and Fetal Growth in Pregnancies Complicated by Obesity
    Hietalati, Samantha
    Pham, Donna
    Arora, Harneet
    Mochizuki, Marina
    Santiago, Gisselle
    Vaught, Jordan
    Lin, Erika
    Mestan, Karen
    Parast, Mana
    Jacobs, Marni
    REPRODUCTIVE SCIENCES, 2022, 29 (SUPPL 1) : 131 - 131
  • [38] Increased placental vascular lesions and neonatal growth restriction characterize pregnancies complicated by placenta previa
    Weiner, Eran
    Miremberg, Hadas
    Grinstein, Ehud
    Mizrachi, Yossi
    Schreiber, Letizia
    Bar, Jacob
    Kovo, Michal
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2016, 214 (01) : S85 - S85
  • [39] Placental volume at 11 to 14 gestational weeks in pregnancies complicated with fetal growth restriction and preeclampsia
    Papastefanou, Ioannis
    Chrelias, Charalambos
    Siristatidis, Charalambos
    Kappou, Dimitra
    Eleftheriades, Makarios
    Kassanos, Dimitrios
    PRENATAL DIAGNOSIS, 2018, 38 (12) : 928 - 935
  • [40] Placental Specific mRNA in the Maternal Circulation Are Globally Dysregulated in Pregnancies Complicated by Fetal Growth Restriction
    Whitehead, Clare L.
    Walker, Susan P.
    Ye, Louie
    Mendis, Sonali
    Kaitu'u-Lino, Tu'uhevaha J.
    Lappas, Martha
    Tong, Stephen
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2013, 98 (03): : E429 - E436